transgender

Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

Craig Hendrix at HIVR4P 2018. Photo by Roger Pebody. Gus Cairns Published: 09 November 2018 Difference “equivalent to four days of PrEP per week rather than seven” A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis […]